South San Francisco, CA Breaking News Headlines Today

News about South San Francisco

Stay current with all the latest and breaking news about South San Francisco, compare headlines and perspectives between news sources on stories happening today. In total, 133 stories have been published about South San Francisco which Ground News has aggregated in the past 3 months.

Local News Publishers

Untracked bias

Suggest a source

Looking for a source we don't already have? Suggest one here.

Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC

100% Center coverage: 3 sources

South San Francisco · South San Francisco See the Story

An Open Letter to the Pompe and Fabry Communities

South San Francisco · South San Francisco Read Article

Denali Therapeutics (NASDAQ:DNLI) Price Target Raised to $40.00 at The Goldman Sachs Group

100% Center coverage: 1 sources

South San Francisco · South San Francisco Read Article

Matthew Angel Purchases 231,482 Shares of Tempest Therapeutics (NASDAQ:TPST) Stock

100% Center coverage: 1 sources

South San Francisco · South San Francisco Read Article

Erasca CMO's Direct Stake Hit Zero. Her Options Position Didn't

100% Left coverage: 1 sources

South San Francisco · South San Francisco Read Article

Xaira Therapeutics Announces the Appointment of Rachel Lane, Ph.D., as Senior Vice President, Business Development and Operations

100% Center coverage: 2 sources

South San Francisco · South San Francisco See the Story

Kodiak’s Phase 3 eye drug success; Innate discontinues anti-CD20 program

South San Francisco · South San Francisco See the Story

News about South San Francisco

News about South San Francisco

Local News Publishers Too Big Arrow Icon

Denali Therapeutics (DNLI) – Analysts’ Recent Ratings Changes

Equities Analysts Offer Predictions for DNLI FY2027 Earnings

SCHS Bruins win 14-3 in softball game against Warriors

Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC

An Open Letter to the Pompe and Fabry Communities

Denali Therapeutics (NASDAQ:DNLI) Price Target Raised to $40.00 at The Goldman Sachs Group

Matthew Angel Purchases 231,482 Shares of Tempest Therapeutics (NASDAQ:TPST) Stock

Erasca CMO's Direct Stake Hit Zero. Her Options Position Didn't

Xaira Therapeutics Announces the Appointment of Rachel Lane, Ph.D., as Senior Vice President, Business Development and Operations

Kodiak’s Phase 3 eye drug success; Innate discontinues anti-CD20 program

Local News Publishers Too Big Arrow Icon

Denali Therapeutics (DNLI) – Analysts’ Recent Ratings Changes

Equities Analysts Offer Predictions for DNLI FY2027 Earnings

SCHS Bruins win 14-3 in softball game against Warriors

Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC

An Open Letter to the Pompe and Fabry Communities

Denali Therapeutics (NASDAQ:DNLI) Price Target Raised to $40.00 at The Goldman Sachs Group

Matthew Angel Purchases 231,482 Shares of Tempest Therapeutics (NASDAQ:TPST) Stock

Erasca CMO's Direct Stake Hit Zero. Her Options Position Didn't

Xaira Therapeutics Announces the Appointment of Rachel Lane, Ph.D., as Senior Vice President, Business Development and Operations

Kodiak’s Phase 3 eye drug success; Innate discontinues anti-CD20 program

Local News Publishers

Local News Publishers